NCT07342881: Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

Sponsor: Aligos Therapeutics. Phase: PHASE1. Conditions: Chronic Hepatitis B Infection